Financial Freedom LLC’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Financial Freedom LLC’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.2K	Buy	388 +1	+0.3%	+$106	0.02%	182
2025 Q4	$40.4K	Buy	387 +1	+0.3%	+$101	0.02%	176
2025 Q3	$35.7K	Buy	386 +1	+0.3%	+$88	0.02%	186
2025 Q2	$30.7K	Buy	385 +2	+0.5%	+$160	0.02%	195
2025 Q1	$33.2K	Buy	383 +1	+0.3%	+$85	0.02%	190
2024 Q4	$31.6K	Buy	382 +1	+0.3%	+$86	0.02%	187
2024 Q3	$33.2K	Sell	381 -51	-12%	-$4.36K	0.02%	186
2024 Q2	$35.6K	Buy	432 +53	+14%	+$4.21K	0.02%	181
2024 Q1	$30.4K	Hold	379	–	–	0.02%	189
2023 Q4	$28.8K	Buy	379 +1	+0.3%	+$71	0.02%	193
2023 Q3	$27.3K	Buy	378 +1	+0.3%	+$77	0.02%	190
2023 Q2	$28.5K	Buy	377 +1	+0.3%	+$76	0.02%	187
2023 Q1	$28.6K	Buy	376 +1	+0.3%	+$77	0.02%	184
2022 Q4	$29.5K	Buy	+375	New	+$28.8K	0.02%	178

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Financial Freedom LLC's PJP Position: Q1 2026 in Review

Financial Freedom LLC increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.26% in Q1 2026, buying an estimated $106 and bringing the position to 388 shares worth $40.2K. The position accounts for 0.02% of the portfolio, ranked #182.

Financial Freedom LLC first reported a position in PJP in Q4 2022 and has held it in 14 quarters since. The position peaked at $40.4K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

Financial Freedom LLC held 388 shares of Invesco Pharmaceuticals ETF worth $40.2K as of Q1 2026.
Financial Freedom LLC bought 1 Invesco Pharmaceuticals ETF share in Q1 2026, an estimated $106.
Invesco Pharmaceuticals ETF made up 0.02% of Financial Freedom LLC's portfolio in Q1 2026, its #182 holding.
Financial Freedom LLC first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and has held it in 14 quarters since.
Financial Freedom LLC's Invesco Pharmaceuticals ETF position peaked at $40.4K in Q4 2025.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.